HOME >> BIOLOGY >> NEWS
Rhesus monkeys in Nepal may provide new alternative for HIV/AIDS research

Scientists investigating the genetic makeup of rhesus macaque monkeys, a key species used in biomedical research, have found the rhesus in Nepal may provide a suitable alternative to alleviate a critical shortage of laboratory animals used in work to develop vaccines against diseases such as HIV/AIDS.

Writing in the cover story of the current issue of the American Journal of Primatology, researchers headed by Randall Kyes of the University of Washington report that the Nepali macaques are more closely related genetically to rhesus macaques from India than rhesus macaques of China.

This is important because Indian-origin animals have been used for more than half a century in biomedical and behavioral research. Rhesus macaques have contributed to the discovery of vaccines to prevent diseases such as polio and yellow fever, and represent one of the most widely used primate models for AIDS-related research. India, however, banned the export of all macaques in 1978, thus leading to the current shortage. Although China has been exporting captive-bred animals for sometime, scientists have noted a number of behavioral and physiological differences in disease progression between animals from the two countries, and the Indian-origin macaques are generally preferred in research on certain diseases.

The new study was spearheaded by Kyes, a primatologist and head of the UW's Division of International Programs at the Washington National Primate Research Center, in collaboration with Mukesh Chalise, president of the Nepal Biodiversity Research Society and a zoologist at Tribhuvan University in Nepal.

Blood samples from 21 Nepali rhesus macaques living at a temple site in Kathmandu were obtained as part of a comprehensive health screening conducted at the temple. These samples were compared with existing samples collected from more than 300 Indian- and Chinese-origin rhesus macaques.

The researchers did sequence analyses of mitochondrial DNA and e
'"/>

Contact: Joel Schwarz
joelsl@u.washington.edu
206-543-2580
University of Washington
31-May-2006


Page: 1 2 3

Related biology news :

1. Rhesus macaque genome may hold clues for human health and evolution
2. DNA sequence of Rhesus macaque has evolutionary, medical implications
3. LSU professors monkey around with the Rhesus Macaque genome
4. Rhesus monkeys can assess the visual perspective of others when competing for food
5. Clues to future evolution of HIV come from African green monkeys
6. Brain, size and gender surprises in latest fossil tying humans, apes and monkeys
7. Antidepressants stimulate new nerve cells in adult monkeys, may have implications for humans
8. Social imitation in neonatal monkeys
9. Apes -- not monkeys -- ace IQ tests
10. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
11. Active inbreeding avoidance in wild capuchin monkeys

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rhesus monkeys Nepal may provide new alternative for HIV AIDS research

(Date:5/21/2013)... ANN ARBORThe new University of Michigan Water Center ... to support Great Lakes restoration and protection efforts. ... will support diverse projects, including efforts to track ... effectiveness of techniques to control non-native weedy plant ... and monitor fish responses to restoration activities. , ...
(Date:5/21/2013)... world,s largest scientific society, invites news media coverage ... 8-12, 2013, in Indianapolis, Ind. It will take ... area hotels. , With more than 7,100 presentations ... from astronomy to zoology ― the meeting will ... assortment of spot news and feature possibilities. The ...
(Date:5/21/2013)... May 21, 2013 Royal Philips Electronics (NYSE: ... world,s first portable ultrasound with Philips, industry leading Live ... The CX50 xMATRIX with available Live 3D TEE and ... at the EuroPCR, official meeting for the European ... Since its launch in 2012, Philips CX50 xMATRIX ...
Breaking Biology News(10 mins):U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
(Date:5/21/2013)... 2013 Bed bugs have become so widespread ... Products, many turn to chemical-based pesticides for help to completely ... environmental risks those solutions present, the company advised the public ... instead. , According to My Cleaning Products, chemical-based pesticides ... to be. It shared that the pests have already developed ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3
Cached News: